{{Rsnum
|rsid=6977660
|Gene=TMEM196
|Chromosome=7
|position=19765857
|Orientation=plus
|GMAF=0.3499
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=TMEM196
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 73.8 | 26.2 | 0.0
| HCB | 11.1 | 57.8 | 31.1
| JPT | 13.4 | 46.4 | 40.2
| YRI | 32.4 | 44.8 | 22.8
| ASW | 32.1 | 55.4 | 12.5
| CHB | 11.1 | 57.8 | 31.1
| CHD | 22.2 | 47.2 | 30.6
| GIH | 45.0 | 46.0 | 9.0
| LWK | 26.6 | 43.1 | 30.3
| MEX | 41.1 | 53.6 | 5.4
| MKK | 38.5 | 49.4 | 12.2
| TSI | 78.2 | 21.8 | 0.0
| HapMapRevision=28
}}

{{GWAS Summary
|SNP=rs6977660
|PubMedID=17903292
|Condition=Thyroid stimulating hormone
|Gene=Intergenic
|Risk Allele=
|pValue=4.00E-006
|OR=NA
|95CI=
|OA=1
}}

{{PharmGKB
|RSID=rs6977660
|Name_s=
|Gene_s=TMEM196
|Feature=
|Evidence=PubMed ID:17903292; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: A genome-wide association for kidney function and endocrine-related traits in the NHLBI's Framingham Heart Study (Initial Sample Size: 810-1,010 individuals depending on measure (Framingham); Replication Sample Size: NR). This variant is associated with Thyroid stimulating hormone level.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356362
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs6977660
|overall_frequency_n=40
|overall_frequency_d=128
|overall_frequency=0.3125
|n_genomes=29
|n_genomes_annotated=0
|n_haplomes=34
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}